全文获取类型
收费全文 | 13932篇 |
免费 | 541篇 |
国内免费 | 122篇 |
专业分类
耳鼻咽喉 | 502篇 |
儿科学 | 685篇 |
妇产科学 | 585篇 |
基础医学 | 916篇 |
口腔科学 | 609篇 |
临床医学 | 1142篇 |
内科学 | 3155篇 |
皮肤病学 | 240篇 |
神经病学 | 931篇 |
特种医学 | 563篇 |
外科学 | 3115篇 |
综合类 | 240篇 |
一般理论 | 1篇 |
预防医学 | 254篇 |
眼科学 | 669篇 |
药学 | 518篇 |
中国医学 | 28篇 |
肿瘤学 | 442篇 |
出版年
2024年 | 9篇 |
2023年 | 90篇 |
2022年 | 182篇 |
2021年 | 289篇 |
2020年 | 192篇 |
2019年 | 294篇 |
2018年 | 340篇 |
2017年 | 302篇 |
2016年 | 421篇 |
2015年 | 560篇 |
2014年 | 625篇 |
2013年 | 774篇 |
2012年 | 1012篇 |
2011年 | 1056篇 |
2010年 | 636篇 |
2009年 | 552篇 |
2008年 | 1086篇 |
2007年 | 1175篇 |
2006年 | 1125篇 |
2005年 | 1012篇 |
2004年 | 817篇 |
2003年 | 681篇 |
2002年 | 529篇 |
2001年 | 165篇 |
2000年 | 141篇 |
1999年 | 145篇 |
1998年 | 60篇 |
1997年 | 44篇 |
1996年 | 39篇 |
1995年 | 26篇 |
1994年 | 24篇 |
1993年 | 22篇 |
1992年 | 20篇 |
1991年 | 23篇 |
1990年 | 19篇 |
1989年 | 8篇 |
1988年 | 15篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1980年 | 3篇 |
1977年 | 3篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1971年 | 4篇 |
1970年 | 2篇 |
1969年 | 5篇 |
1967年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
83.
84.
85.
86.
Kuehne T Yilmaz S Steendijk P Moore P Groenink M Saaed M Weber O Higgins CB Ewert P Fleck E Nagel E Schulze-Neick I Lange P 《Circulation》2004,110(14):2010-2016
87.
Wenjie Wang Brendan Murphy Serdar Yilmaz Marcello Tonelli Jennifer MacRae Braden J. Manns 《Clinical journal of the American Society of Nephrology》2008,3(1):78-84
Background and objectives: Concern about primary fistula failure may contribute to the underuse of arteriovenous fistula. The objective of this study was to investigate the baseline clinical parameters associated with primary fistula success.Design, setting, participants, & measurements: Consecutive incident patients who commenced dialysis during a 28-mo period in a regional renal program were studied. Data on patient-related variables and on surgical approach (e.g., whether the surgeons routinely assess vessel size during the operation) were collected. Primary fistula success was defined as an arteriovenous fistula that was able to afford successful dialysis for 3 h with blood pump speed of ≥300 ml/min for three consecutive sessions.Results: A total of 205 (69%) patients had an AVF attempted as their first vascular access. The overall primary success rate was 64% and was similar for radiocephalic and brachiocephalic fistula. Logistic regression was done separately for patients with the two types of fistula because of the presence of statistical interaction. For radiocephalic fistula, male gender was the only parameter associated with primary fistula success (odds ratio 3.57; P = 0.01). The presence of comorbidity was not significantly associated with primary fistula failure.Conclusions: Despite significant patient comorbidity, there was a high primary fistula success rate among this incident hemodialysis cohort. Given that vessel size may be the ultimate determinant of fistula success, if surgeons assess vessel size perioperatively, then the presence of significant comorbidity might not preclude arteriovenous fistula from being attempted as the initial access.Given the well-documented advantages of arteriovenous fistula (AVF) over arteriovenous graft and central venous catheter (CVC), the current Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines suggest that AVF should be attempted as the initial vascular access in at least 50% of incident patients and that at least 40% of prevalent hemodialysis (HD) patients should undergo dialysis with an AVF (1–5). Despite these recommendations, it is clear that AVF are underused in many centers in North America, especially when compared with European centers (6,7). Recent data suggest that only 32% of prevalent US HD patients undergo dialysis with an AVF (8). In Canada, AVF are used by 53% of prevalent and only 26% of incident HD patients (7).One of the fears that may reduce the use of AVF is the high primary fistula failure rate (i.e., failure of AVF to mature) (9). Identifying risk factors that contribute to primary fistula failure may help clinicians and patients make an informed decision as to for whom to attempt an AVF. Only a few studies have prospectively examined the risk factors associated with primary fistula failure, which has been reported in 20 to 50% of patients (9–12).Most studies that have evaluated factors that are associated with primary fistula failure have typically used a retrospective design. For instance, Miller et al. (10) reported higher primary fistula failure rate in older and female patients with diabetes, although small numbers and a highly selected patient population limit the generalizability of these results. Feldman et al. (13) published data from a larger cohort (348 patients), reporting a primary success rate of 54%. Preexisting cerebrovascular disease, older age, and commencement of dialysis before access creation were noted to be associated with higher primary fistula failure in their study. Ravani et al. (11) noted that cardiovascular disease and late referral to nephrologists were associated with lower primary AVF success in patients from northern Italy.More recently, Lok et al. (14) studied a cohort of 422 HD patients who were undergoing their first AVF placement to identify preoperative clinical characteristics that are predictive of fistula failure to mature and to use this information to develop a prediction rule to estimate the risk for fistula failure to mature. This prediction rule was validated in an external data set from five North American centers. Age, peripheral vascular disease, coronary artery disease, and white race all were associated with fistula failure to mature in their study; however, in this and the previously mentioned studies, it is not clear whether there was any consistent surgical assessment performed perioperatively to guide fistula placement; as such, the results may not be applicable to programs that use pre- or intraoperative surgical assessment to guide fistula placement.Given these uncertainties, we sought to determine the association of various baseline clinical parameters with primary fistula success in a cohort that consisted of all incident dialysis patients between July 1, 1999, and November 1, 2001, in Calgary, Alberta, Canada, the majority of whom had an indirect assessment of vessel diameter intraoperatively to guide the location of fistula placement. 相似文献
88.
89.
Karti SS Ovali E Ozgur O Yilmaz M Sonmez M Ratip S Ozdemir F 《Hepato-gastroenterology》2003,50(54):1864-1866
BACKGROUND/AIMS: Apoptotic and anti-proliferative effects of heparin on a number of cancers have been described. There have been no studies analyzing the effect of heparin on human hepatoma cells. The aim of this study was to investigate the effect of heparin on human hepatoma cell line, HepG2. METHODOLOGY: HepG2 cell line was cultured with different concentrations of heparin. Colony count, viability assay, percentage of the apoptosis and proliferative index were assessed at the end of the 7th day. Trypan blue was used to assess viability. Apoptosis and proliferative indexes were assessed by flow-cytometry. RESULTS: Hepatoma cells were arrested at the G0/G1 phase with heparin incubation and proliferative indexes decreased significantly in 20, 40 and 80 U/mL of heparin concentrations in comparison with the control (36 +/- 1%, 30 +/- 5% and 29 +/- 8% vs. 44 +/- 1%, p < 0.01). Flow cytometry revealed a statistically significant increase in apoptosis in groups incubated with 40 and 80 U/mL of heparin in comparison with the control (39 +/- 26% and 58 +/- 18% vs. 0.83 +/- 1.3%, p < 0.01). Colony counts per well and viable cells per microL decreased significantly in 80 U/mL of heparin. CONCLUSIONS: Heparin leads to a significant anti-proliferative and an apoptotic effect on human hepatoma cells in vitro. 相似文献
90.
Ceyhan M Yildirim I Tekeli A Yurdakok M Us E Altun B Kutluk T Cengiz AB Gurbuz V Barin C Bagdat A Cetinkaya D Gur D Tuncel O 《American journal of infection control》2008,36(6):453-457
Three clusters of Chryseobacterium meningosepticum infections in a tertiary health center in July 2006 and January 2007 involving 8 newborns and 5 older children were investigated. The index patient was from the neonatal intensive care unit, and the older patients were from other pediatric wards. Cultures were obtained from the environment and from health care workers' hands as part of an outbreak investigation. C meningosepticum was isolated from hand cultures obtained from a senior resident and from environmental cultures obtained from powdered infant formula, an electrical button, a computer keyboard, phone, a doorknob, and an Ambu bag. Antibiogram typing and enterobacterial repetitive intergenic consensus sequence polymerase chain reaction indicated that all of the isolates were epidemiologically related. Nine patients improved on antimicrobial treatment, and 4 premature infants died after the infection. C meningosepticum is a well-known etiologic agent for nosocomial infections involving newborns and immunocompromised patients. Wet and dry environmental surfaces and equipment may act as a source or play a role in disseminating the microorganism. Outbreaks may be controlled with strong emphasis on infection control measures. 相似文献